Progress in Surgical Diagnosis and Treatment of Drug-resistant Epilepsy

Neural Injury and Functional Reconstruction ›› 2023, Vol. 18 ›› Issue (6) : 346-348.

PDF(1411 KB)
中国科技核心期刊
美国《化学文摘》CAS数据库收录
日本科学技术振兴机构数据库收录
湖北省优秀期刊
中国知网网络首发期刊
PDF(1411 KB)
Neural Injury and Functional Reconstruction ›› 2023, Vol. 18 ›› Issue (6) : 346-348.
综述

Progress in Surgical Diagnosis and Treatment of Drug-resistant Epilepsy

Author information +
History +

Abstract

Epilepsy is a clinical syndrome caused by highly synchronous abnormal discharge of neurons in the brain, which is caused by a variety of reasons. With a prevalence of 0.8% to 1.2%, epilepsy represents one of the most frequent chronic neurological disorders. 30% to 40% of patients suffer from drug-resistant epilepsy (regular use of first-line antiepileptic drugs for 2 years still cannot adequately control seizures). Epilepsy surgery represents a valuable treatment option for 10% to 50% of these patients. Epilepsy surgery aims to control seizures by resection of the epileptogenic tissue while avoiding neuropsychological and functional disorders by sparing essential brain areas. In this paper, the preoperative evaluation, location of epileptogenic focus, choice of operative mode and prognosis of refractory epilepsy surgery are summarized.

Key words

epilepsy

Cite this article

Download Citations
Progress in Surgical Diagnosis and Treatment of Drug-resistant Epilepsy[J]. Neural Injury and Functional Reconstruction. 2023, 18(6): 346-348
PDF(1411 KB)

Accesses

Citation

Detail

Sections
Recommended

/